Abstract
The blood-brain barrier has long been a barrier to the treatment of neurological diseases in the brain. It protects brain tissues from damage while limiting the access of drugs to the brain for drug delivery, so nanocarriers with smaller particle size are chosen to break the blood-brain barrier. This review summarizes the structural properties of nanodiamond, the interaction mechanism between nanodiamond and blood-brain barrier, and the application of nanodiamond as a carrier in the diagnosis and treatment of neurological diseases, which provides the theoretical basis for the subsequent diagnosis and treatment of neurological diseases.
Publisher
Darcy & Roy Press Co. Ltd.
Reference14 articles.
1. Tang, G. F., Zhang, M. R., Liu, Q. Q., Tian, X. M., & Mai, R. R.. (2022). Applications of nanodiamonds in the diagnosis and treatment of neurological diseases. Journal of Nanoparticle Research, 24(3), 1-23.
2. Yang Zhijun, Peng Mingsheng, Xie Xiande, et al. Assets of Hydrogen in Natural Diamond Structure[J]. Minerals and Geology, 2001, 15(2):141-145.
3. Wang Zhicheng. Structural properties and application research of nano-diamond [D]. Nanjing University of Science and Technology, 2004.
4. Ghose AK, Viswanadhan VN, Wendoloski JJ (1999) A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery 1 A qualitative and quantitative characterization of known drug databases. J Comb Chem 1:55–68
5. Qin Wei, Luo Yong, Luo Yan. Application prospects of drug-loaded nanoparticles in the treatment of central nervous system diseases [J]. Foreign Medicine (Cerebrovascular Diseases Volume), 2004 (11): 821-824.